Astria Therapeutics Inc (ATXS) earnings · $382.1M cap
These earnings events as JSON? API free 100/dayAstria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
This ATXS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
When the next ATXS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ATXS. We will not invent a beat or miss.
Not investment advice. Full ATXS research stays on the stock page; the tape stays on the quote page.
ATXS earnings FAQ
What are ATXS's latest revenue and net income?
Latest cached Astria Therapeutics Inc (ATXS) revenue for Sep 30, 2025 was $706.0K. Net income was -$98.4M. Statements: https://lician.com/financials/atxs
What is ATXS's latest diluted EPS?
Latest cached Astria Therapeutics Inc (ATXS) diluted EPS for Sep 30, 2025 was -$0.55.
What period does the latest ATXS earnings print cover?
The latest cached Astria Therapeutics Inc (ATXS) earnings print covers Sep 30, 2025. The prior cached period on this page is Sep 30, 2024.
Where are ATXS earnings listed?
Cached earnings facts for Astria Therapeutics Inc (ATXS) are listed at https://lician.com/earnings/atxs. Statements: https://lician.com/financials/atxs
Not investment advice.